Filter the latest scan's published facts — sector, size, yield, valuation — or rank them with a preset: cheapest, fastest growing, most profitable. Every view shows what is in the filings and prices; none ranks opportunity. The model behind the statuses showed no predictive power, and nothing here is a recommendation.
Scan of 2026-08-31 · 2,409 names scored · prices as of that date
285 names match — page 3 of 3 · Export CSV
| Ticker | Company | Sector | Market cap ↑ | P/E | P/B | Div. yield | 1M change | Composite %ile | Status |
|---|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | Pharma & chemicals | $5.49B | — |
Figures are as of the scan date, from unadjusted prices and point-in-time filings. "—" means the scan published no figure — deliberately, where a ratio's denominator made it meaningless. A hole is honest; a confidently wrong number is not. "Composite %ile" is the position in a ranking with no measurable predictive power — context for the status, not a score.
Never the absolute multiple alone. A P/E of 9 is a fact; whether it is low depends on what you hold it against.
The five-year window is the empirically privileged one. Cheap against its sector and cheap against its own history are different claims, and a stock can be one without being the other — which is the whole reason both columns are shown rather than blended into a single score.
| 3.03 |
| — |
| up 18.73% |
| 6.3 |
pass |
| ERAS | Erasca, Inc. Common Stock | Pharma & chemicals | $5.56B | — | 14.12 | — | down 1.49% | 16.6 | pass |
| BCPC | Balchem Corporation | Pharma & chemicals | $5.65B | 36.5 | 4.40 | 0.55% | up 4.97% | 65.7 | pass |
| LGND | Ligand Pharmaceuticals Inc. | Pharma & chemicals | $5.69B | 45.7 | 5.71 | — | down 1.20% | 72.9 | pass |
| SXT | Sensient Technology Corporation | Pharma & chemicals | $5.70B | 42.4 | 4.68 | 1.22% | up 9.11% | 42.1 | pass |
| DNTH | Dianthus Therapeutics, Inc. Common Stock | Pharma & chemicals | $5.76B | — | 4.80 | — | down 1.23% | 28.6 | pass |
| XENE | Xenon Pharmaceuticals Inc | Pharma & chemicals | $5.82B | — | 4.35 | — | down 3.91% | 22.7 | pass |
| MIRM | Mirum Pharmaceuticals, Inc. Common Stock | Pharma & chemicals | $5.97B | — | 24.63 | — | down 7.46% | 25.1 | pass |
| COGT | Cogent Biosciences, Inc. Common Stock | Pharma & chemicals | $5.98B | — | 9.84 | — | down 10.10% | 13.2 | pass |
| LQDA | Liquidia Corporation Common Stock | Pharma & chemicals | $6.02B | — | 55.44 | — | down 18.95% | 19.0 | pass |
| KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | Pharma & chemicals | $6.03B | 102.2 | 9.96 | — | up 5.77% | 49.5 | pass |
| TVTX | Travere Therapeutics, Inc. Common Stock | Pharma & chemicals | $6.12B | — | 62.03 | — | up 18.59% | 20.5 | pass |
| ELF | e.l.f. Beauty, Inc. | Pharma & chemicals | $6.44B | 244.8 | 5.70 | — | up 31.56% | 6.1 | pass |
| LNTH | Lantheus Holdings, Inc | Pharma & chemicals | $6.57B | 28.1 | 5.42 | — | up 1.32% | 86.7 | pass |
| CGON | CG Oncology, Inc. Common stock | Pharma & chemicals | $6.61B | — | 6.06 | — | up 5.58% | 29.1 | pass |
| SRRK | Scholar Rock Holding Corporation Common Stock | Pharma & chemicals | $6.77B | — | 24.51 | — | up 20.10% | 11.1 | pass |
| SYRE | Spyre Therapeutics, Inc. Common Stock | Pharma & chemicals | $7.04B | — | 10.50 | — | down 9.15% | 23.0 | pass |
| RYTM | Rhythm Pharmaceuticals, Inc. Common Stock | Pharma & chemicals | $7.26B | — | 59.10 | — | up 6.93% | 5.9 | pass |
| HXL | Hexcel Corporation | Pharma & chemicals | $7.37B | 67.3 | 5.82 | 0.77% | down 9.99% | 62.0 | pass |
| MOS | The Mosaic Company | Pharma & chemicals | $7.67B | 14.2 | 0.65 | 3.65% | up 9.04% | 37.0 | pass |
| AXTA | Axalta Coating Systems Ltd. | Pharma & chemicals | $7.79B | 20.6 | 3.22 | — | up 1.70% | 73.9 | pass |
| ALKS | Alkermes Inc. plc | Pharma & chemicals | $7.82B | 32.4 | 4.47 | — | down 4.08% | 72.7 | pass |
| NEU | NewMarket Corporation | Pharma & chemicals | $8.26B | 19.7 | 4.77 | 1.31% | up 5.59% | 68.4 | pass |
| TGTX | TG Therapeutics, Inc. | Pharma & chemicals | $8.31B | 18.6 | 14.26 | — | up 4.36% | 84.4 | pass |
| IMVT | Immunovant, Inc. Common Stock | Pharma & chemicals | $8.32B | — | 9.76 | — | up 5.70% | 20.2 | pass |
| TWST | Twist Bioscience Corporation Common Stock | Pharma & chemicals | $8.64B | — | 18.98 | — | up 51.83% | 21.3 | pass |
| PCVX | Vaxcyte, Inc. Common Stock | Pharma & chemicals | $8.77B | — | 2.93 | — | up 12.32% | 32.9 | pass |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pharma & chemicals | $8.95B | — | 6.99 | — | up 1.71% | 15.7 | pass |
| PTGX | Protagonist Therapeutics, Inc | Pharma & chemicals | $9.49B | — | 14.48 | — | up 8.13% | 28.2 | pass |
| ESI | Element Solutions Inc. | Pharma & chemicals | $9.61B | 50.4 | 3.51 | 0.90% | down 3.24% | 47.7 | pass |
| WLK | Westlake Corporation | Pharma & chemicals | $9.63B | — | 1.13 | 2.83% | up 6.48% | 15.6 | pass |
| PRAX | Praxis Precision Medicines, Inc. Common Stock | Pharma & chemicals | $9.76B | — | 6.92 | — | up 13.80% | 18.4 | pass |
| KYMR | Kymera Therapeutics, Inc. Common Stock | Pharma & chemicals | $9.76B | — | 6.34 | — | up 14.90% | 25.0 | pass |
| IONS | Ionis Pharmaceuticals, Inc. Common Stock | Pharma & chemicals | $10.01B | — | 20.38 | — | up 16.59% | 10.0 | pass |
| APGE | Apogee Therapeutics, Inc. Common Stock | Pharma & chemicals | $10.12B | — | 8.05 | — | up 0.74% | 23.7 | pass |
| RGEN | Repligen Corp | Pharma & chemicals | $10.21B | 208.8 | 4.85 | — | up 28.35% | 27.4 | pass |
| AXSM | Axsome Therapeutics, Inc | Pharma & chemicals | $10.21B | — | — | — | down 8.93% | 24.0 | pass |
| SMMT | Summit Therapeutics Inc. Common Stock | Pharma & chemicals | $10.57B | — | 19.36 | — | up 4.61% | 0.5 | pass |
| KRYS | Krystal Biotech, Inc. Common Stock | Pharma & chemicals | $10.58B | 51.6 | 8.29 | — | up 5.35% | 74.6 | pass |
| TECH | Bio-Techne Corp. | Pharma & chemicals | $11.32B | 154.2 | 5.43 | 0.44% | up 0.31% | 33.9 | pass |
| ARWR | Arrowhead Research Corporation | Pharma & chemicals | $11.58B | — | 18.86 | — | down 2.67% | 29.7 | pass |
| EL | The Estee Lauder Companies Inc. Class A | Pharma & chemicals | $11.71B | — | 2.93 | 1.71% | up 21.93% | 10.1 | pass |
| ELAN | Elanco Animal Health Incorporated Common Stock | Pharma & chemicals | $11.95B | — | 1.84 | — | down 9.29% | 40.3 | pass |
| CORT | Corcept Therapeutics Inc. | Pharma & chemicals | $12.17B | 122.1 | 19.07 | — | down 1.00% | 39.5 | pass |
| MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | Pharma & chemicals | $12.44B | — | 22.90 | — | up 15.56% | 10.0 | pass |
| BMRN | BioMarin Pharmaceuticals Inc | Pharma & chemicals | $12.61B | 36.1 | 2.03 | — | up 8.68% | 43.1 | pass |
| HALO | Halozyme Therapeutics, Inc. | Pharma & chemicals | $12.62B | 39.8 | 57.47 | — | up 29.02% | 60.9 | pass |
| RPM | RPM International, Inc. | Pharma & chemicals | $13.31B | 19.3 | 4.23 | 2.07% | down 2.77% | 62.2 | pass |
| EXEL | Exelixis Inc | Pharma & chemicals | $13.86B | 17.7 | 7.16 | — | up 3.04% | 87.3 | pass |
| CRL | Charles River Laboratories International, Inc. | Pharma & chemicals | $13.88B | — | 4.72 | — | up 23.97% | 31.5 | pass |
| NBIX | Neurocrine Biosciences Inc | Pharma & chemicals | $15.50B | 32.4 | 4.55 | — | down 7.66% | 63.5 | pass |
| JAZZ | Jazz Pharmaceuticals, Inc. | Pharma & chemicals | $15.72B | — | 3.47 | — | down 0.86% | 45.4 | pass |
| ALB | Albemarle Corporation | Pharma & chemicals | $15.91B | — | 1.62 | 1.20% | up 14.73% | 30.8 | pass |
| MEDP | Medpace Holdings, Inc. Common Stock | Pharma & chemicals | $16.96B | 37.6 | 28.35 | — | up 2.92% | 58.9 | pass |
| VTRS | Viatris Inc. Common Stock | Pharma & chemicals | $19.82B | — | 1.35 | 2.91% | down 5.98% | 50.0 | pass |
| LYB | LyondellBasell Industries N.V. Class A | Pharma & chemicals | $21.01B | — | 2.09 | 5.29% | up 4.83% | 28.5 | pass |
| CF | CF Industries Holding, Inc. | Pharma & chemicals | $21.08B | 11.7 | 3.95 | 1.61% | up 3.87% | 90.5 | pass |
| UTHR | United Therapeutics Corp | Pharma & chemicals | $21.52B | 16.1 | 3.65 | — | down 1.42% | 85.4 | pass |
| DOW | Dow Inc. | Pharma & chemicals | $21.72B | — | 1.42 | 4.59% | up 0.76% | 32.0 | pass |
| IFF | International Flavors & Fragrances Inc. | Pharma & chemicals | $22.03B | — | 1.56 | 1.85% | up 8.97% | 40.1 | pass |
| CHD | Church & Dwight Co., Inc. | Pharma & chemicals | $24.22B | 32.9 | 5.79 | 1.22% | up 0.98% | 73.3 | pass |
| INCY | Incyte Genomics Inc | Pharma & chemicals | $24.64B | 19.1 | 4.38 | — | up 3.10% | 90.1 | pass |
| ROIV | Roivant Sciences Ltd. Common Shares | Pharma & chemicals | $24.95B | — | 5.51 | — | up 2.15% | 39.8 | pass |
| INSM | Insmed, Inc. | Pharma & chemicals | $26.38B | — | 37.42 | — | up 23.55% | 1.4 | pass |
| ALNY | Alnylam Pharmaceuticals, Inc. | Pharma & chemicals | $32.12B | 102.4 | 29.87 | — | up 17.11% | 25.9 | pass |
| ZTS | ZOETIS INC. | Pharma & chemicals | $32.41B | 12.1 | 10.02 | 2.71% | down 0.25% | 49.3 | pass |
| RPRX | Royalty Pharma plc Class A Ordinary Shares | Pharma & chemicals | $35.39B | 45.9 | 3.56 | 1.51% | up 5.10% | 81.6 | pass |
| KVUE | Kenvue Inc. | Pharma & chemicals | $36.25B | 24.7 | 3.42 | 4.41% | down 1.87% | 55.8 | pass |
| BIIB | Biogen Inc. Common Stock | Pharma & chemicals | $37.13B | 28.7 | 1.99 | — | up 6.75% | 70.5 | pass |
| RVMD | Revolution Medicines, Inc. Common Stock | Pharma & chemicals | $41.15B | — | 27.44 | — | up 9.62% | 18.0 | pass |
| IQV | IQVIA Holdings Inc. | Pharma & chemicals | $43.59B | 32.0 | 7.01 | — | up 11.14% | 61.6 | pass |
| IDXX | Idexx Laboratories Inc | Pharma & chemicals | $44.11B | 41.6 | 28.35 | — | down 0.43% | 50.6 | pass |
| MRNA | Moderna, Inc. Common Stock | Pharma & chemicals | $55.71B | — | 7.52 | — | up 156.00% | 13.4 | pass |
| DD | DuPont de Nemours, Inc. Common Stock | Pharma & chemicals | $56.19B | — | 4.00 | 0.89% | down 1.76% | 44.0 | pass |
| APD | Air Products & Chemicals, Inc. | Pharma & chemicals | $68.92B | — | 4.40 | 2.33% | up 4.94% | 32.9 | pass |
| ECL | Ecolab, Inc. | Pharma & chemicals | $79.69B | 38.4 | 7.97 | 1.00% | up 2.01% | 68.6 | pass |
| VRTX | Vertex Pharmaceuticals Inc | Pharma & chemicals | $138.40B | 35.0 | 7.15 | — | up 14.13% | 73.7 | pass |
| PFE | Pfizer Inc. | Pharma & chemicals | $161.74B | 20.8 | 1.80 | 6.04% | up 13.79% | 72.1 | pass |
| GILD | Gilead Sciences Inc | Pharma & chemicals | $181.75B | 21.4 | 7.73 | 2.20% | up 12.39% | 85.8 | pass |
| ABT | Abbott Laboratories | Pharma & chemicals | $220.53B | 33.8 | 4.24 | 2.25% | up 4.41% | 48.4 | pass |
| LIN | Linde plc Ordinary Share | Pharma & chemicals | $229.85B | 33.3 | 5.96 | 1.27% | up 2.34% | 72.3 | pass |
| AMGN | Amgen Inc | Pharma & chemicals | $232.01B | 30.1 | 25.25 | 2.31% | up 11.61% | 88.5 | pass |
| PG | Procter & Gamble Company | Pharma & chemicals | $337.93B | 21.1 | 6.17 | 2.96% | up 0.44% | 79.7 | pass |
| JNJ | Johnson & Johnson | Pharma & chemicals | $640.01B | 23.9 | 7.88 | 1.99% | up 3.71% | 98.7 | watch |
| LLY | Eli Lilly & Co. | Pharma & chemicals | $1.04T | 50.3 | 33.27 | 0.58% | up 0.69% | 80.2 | pass |